Like dominant negative CARD11 mutations, CARD14 mutations that attenuate NF-κB activity are associated with AD and hyper-IgE (122), whereas complete absence of CARD14 is not associated with AD (141). The gene discussed is CARD14; the disease is Alzheimer disease.